Khairy M A Zoheir

Prof. Khairy M A Zoheir

National Research Center, Giza, Al Jīzah, Egypt
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2016 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
SASheikh Fayaz Ahmad
Sheikh Fayaz Ahmad
KZKhairy M A Zoheir
Khairy M A Zoheir
MAMushtaq Ahmad Ansari
Mushtaq Ahmad Ansari
ANAhmed Nadeem
Ahmed Nadeem
SBSaleh A. Bakheet
Saleh A. Bakheet
SASabry M. Attia
Sabry M. Attia

21 April 2016 in Immunological Investigations
Verified
Journal Article
Closed access
PDF file
NANaif O. Al-Harbi
Naif O. Al-Harbi
FIFaisal Imam
Faisal Imam
MAMohammed M. Al-Harbi
Mohammed M. Al-Harbi
MAMushtaq Ahmad Ansari
Mushtaq Ahmad Ansari
KZKhairy M A Zoheir
Khairy M A Zoheir
SASheikh Fayaz Ahmad
Sheikh Fayaz Ahmad
Dexamethasone (DEX) is a synthetic glucocorticoid with potent anti-inflammatory effects that is widely used to treat inflammatory diseases. The aim of the present study was to investigate the possible protective effect of DEX on the lipopolysaccharides (LPS)-induced acute lung injury (ALI) in a mouse model. Animals were pretreated with DEX (5 and 10 mg/kg, i.p.) for seven days and acute lung injury was induced by intranasal (i.n.) administration of LPS on day 7. In the present study, administration of LPS resulted in significant increase in neutrophils and lymphocytes count whereas a substantial reduction in T cell subsets (CD3+ and CD4+) and pro-inflammatory (IL-6 and TNF-α) cytokines occurred, which were reversed by DEX treatment. RT-PCR analysis revealed an increased mRNA expression of IL-6, TNF-α, COX-2, iNOS, and NF-κB p65 and decreased IL-10 in the LPS group, which were reversed by treatment with DEX in lung tissues. Western blot analysis revealed an increased expression of COX-2, iNOS and NF-κB p65 in the LPS-group, which was reduced by treatment with DEX. Compared with the LPS group, the DEX treatment also demonstrated a considerable increase in the protein expression level of IL-10 cytokine. Administration of LPS resulted in marked increase in malondialdehyde (MDA) levels and myeloperoxidase (MPO) activity whereas noticeable decrease in glutathione (GSH) content. These changes were significantly reversed by treatment with DEX. The histological examinations revealed protective effect of DEX while LPS group aggravated lung injury. The present findings demonstrate the potent anti-inflammatory action of the DEX against acute lung injury induced by LPS.

1 September 2015 in Pharmacological Research
Verified
Journal Article
Closed access
ANAhmed Nadeem
Ahmed Nadeem
NANaif O. Al-Harbi
Naif O. Al-Harbi
MAMohamed M. Al-Harbi
Mohamed M. Al-Harbi
Ahmed M. El-SherbeenyAhmed M. El-Sherbeeny
Ahmed M. El-Sherbeeny
SASheikh Fayaz Ahmad
Sheikh Fayaz Ahmad
SAShakir D. Al-Sharary
Shakir D. Al-Sharary

1 December 2015 in Pharmacological Research
Verified
Journal Article
Closed access
FIFaisal Imam
Faisal Imam
NANaif O. Al-Harbi
Naif O. Al-Harbi
MAMohammed M. Al-Harbi
Mohammed M. Al-Harbi
MAMushtaq Ahmad Ansari
Mushtaq Ahmad Ansari
KZKhairy M A Zoheir
Khairy M A Zoheir
SASheikh Fayaz Ahmad
Sheikh Fayaz Ahmad

1 July 2015 in Immunobiology
Verified
Journal Article
Closed access
SASheikh Fayaz Ahmad
Sheikh Fayaz Ahmad
MAMushtaq Ahmad Ansari
Mushtaq Ahmad Ansari
KZKhairy M A Zoheir
Khairy M A Zoheir
SBSaleh A. Bakheet
Saleh A. Bakheet
Hesham M. KorashyHesham M. Korashy
Hesham M. Korashy
SASabry M. Attia
Sabry M. Attia

30 August 2016 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
SBSaleh A. Bakheet
Saleh A. Bakheet
MAMohammad Zeed Alzahrani
Mohammad Zeed Alzahrani
MAMushtaq Ahmad Ansari
Mushtaq Ahmad Ansari
ANAhmed Nadeem
Ahmed Nadeem
KZKhairy M A Zoheir
Khairy M A Zoheir
SASheikh Fayaz Ahmad
Sheikh Fayaz Ahmad